Publication

Genetics of blood lipids among similar to 300,000 multi-ethnic participants of the Million Veteran Program

Downloadable Content

Persistent URL
Last modified
  • 05/22/2025
Type of Material
Authors
    Derek Klarin, Harvard Medical SchoolScott M. Damrauer, Corporal Michael Crescenz VA Medical CenterKelly Cho, Boston VA Healthcare SystemYan Sun, Emory UniversityTanya M. Teslovich, Regeneron Genetics CenterJacqueline Honerlaw, Boston VA Healthcare SystemDavid R Gagnon, Boston VA Healthcare SystemScott L. Du Vall, VA Salt Lake City Health Care SystemJin Li, Stanford UniversityGina M. Peloso, Boston UniversityMark Chaffin, Broad Institute of MIT & HarvardAeron M. Small, Corporal Michael Crescenz VA Medical CenterJie Huang, Boston VA Healthcare SystemHua Tang, Stanford UniversityJulie A. Lynch, VA Salt Lake City Health Care SystemYuk-Lam Ho, Boston VA Healthcare SystemDajiang J. Liu, Penn State College of MedicineConnor A. Emdin, Harvard Medical SchoolAlexander H. Li, Regeneron Genetics CenterPeter Wilson, Emory University
Language
  • English
Date
  • 2018-11-01
Publisher
  • Nature Research (part of Springer Nature)
Publication Version
Copyright Statement
  • © 2018, The Author(s), under exclusive licence to Springer Nature America, Inc.
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 1061-4036
Volume
  • 50
Issue
  • 11
Start Page
  • 1514
End Page
  • +
Grant/Funding Information
  • This research was also supported by three additional Department of Veterans Affairs awards (I01-01BX03340, I01-BX002641, and I01-CX001025); and the NIH (T32 HL007734, K01HL125751, R01HL127564).
  • This research is based on data from the Million Veteran Program, Office of Research and Development, Veterans Health Administration; and was supported by the Department of Veterans Affairs (VA) Cooperative Studies Program (CSP) award #G002.
Supplemental Material (URL)
Abstract
  • The Million Veteran Program (MVP) was established in 2011 as a national research initiative to determine how genetic variation influences the health of US military veterans. Here we genotyped 312,571 MVP participants using a custom biobank array and linked the genetic data to laboratory and clinical phenotypes extracted from electronic health records covering a median of 10.0 years of follow-up. Among 297,626 veterans with at least one blood lipid measurement, including 57,332 black and 24,743 Hispanic participants, we tested up to around 32 million variants for association with lipid levels and identified 118 novel genome-wide significant loci after meta-analysis with data from the Global Lipids Genetics Consortium (total n > 600,000). Through a focus on mutations predicted to result in a loss of gene function and a phenome-wide association study, we propose novel indications for pharmaceutical inhibitors targeting PCSK9 (abdominal aortic aneurysm), ANGPTL4 (type 2 diabetes) and PDE3B (triglycerides and coronary disease).
Author Notes
  • Themistocles L. Assimes, M.D., Ph.D., Stanford University School of Medicine & VA Palo Alto Health Care System, Suite 300, 1070 Arastradero Road, Palo Alto, CA 94304-1334, Tel: (650) 498-4154, tassimes@stanford.edu.
Keywords
Research Categories
  • Health Sciences, Medicine and Surgery
  • Biology, Genetics

Tools

Relations

In Collection:

Items